Skip to main content

and
  1. Article

    Open Access

    BluePrint breast cancer molecular subty** recognizes single and dual subtype tumors with implications for therapeutic guidance

    BluePrint (BP) is an 80-gene molecular subty** test that classifies early-stage breast cancer (EBC) into Basal, Luminal, and HER2 subtypes. In most cases, breast tumors have one dominant subtype, representat...

    Midas M. Kuilman, Architha Ellappalayam in Breast Cancer Research and Treatment (2022)